Xanax owner fends off ‘Canvax’ mark in EU

The pharma manufacturer defeats an Italian hemp firm’s EU trademark bid | Claimed name could be confused for its blockbuster drug Xanax | EUIPO found strong market position and product overlap created risk of confusion.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Mental health IP toolkit: Diversity Champ’s stress-busting tips

3 April 2025 The pressures of IP law can take a serious toll on mental wellbeing. Boult Wade Tennant partner and WIPR Diversity Champion, Susi Fish, shares her experiences and tips for managing stress.

Americas

US customs raids find thousands of fake COVID-19 test kits

5 May 2020 US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

Xanax owner fends off ‘Canvax’ mark in EU

More on this story

Editor's picks

Editor's picks

More features